絞り込み

16555

広告

「elotuzumab」の検索結果

206件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

[Immunopathogenesis and appropriate use of monoclonal antibody agents in multiple myeloma].

Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whites.

Elotuzumab: A Review in Relapsed and/or Refractory Multiple Myeloma.

Practical Considerations for Antibodies in Myeloma.

Elotuzumab Plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 4-Year Follow-Up and Analysis of Relative Progression-Free Survival From the Randomized ELOQUENT-2 Trial.

Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study.

Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.

Carfilzomib.

Pomalidomide.

The Multiple Myeloma Drug Pipeline-2018: A Review of Small Molecules and Their Therapeutic Targets.

Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and Elotuzumab.

Maintenance and continuous therapy for multiple myeloma.

Interference of Therapeutic Monoclonal Antibodies With Routine Serum Protein Electrophoresis and Immunofixation in Patients With Myeloma: Frequency and Duration of Detection of Daratumumab and Elotuzumab.

[Multiple myeloma: update on pathophysiology and management].

Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016).

Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study.

A look at treatment strategies for relapsed multiple myeloma.

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります